Osteopontin(OPN)-induced increase in human mammary epithelial cell invasiveness is urokinase (uPA)-dependent.
about
Osteopontin induction of hyaluronan synthase 2 expression promotes breast cancer malignancyIdentification of genes differentially expressed between benign and osteopontin transformed rat mammary epithelial cellsSoluble bone-derived osteopontin promotes migration and stem-like behavior of breast cancer cellsRNA aptamer blockade of osteopontin inhibits growth and metastasis of MDA-MB231 breast cancer cells.Deletion of the thrombin cleavage domain of osteopontin mediates breast cancer cell adhesion, proteolytic activity, tumorgenicity, and metastasisEffects of osteopontin inhibition on radiosensitivity of MDA-MB-231 breast cancer cellsRole of the integrin-binding protein osteopontin in lymphatic metastasis of breast cancer.Role of plasma osteopontin as a biomarker in locally advanced breast cancerInduction of osteopontin expression by nicotine and cigarette smoke in the pancreas and pancreatic ductal adenocarcinoma cellsPleural fluid osteopontin, vascular endothelial growth factor, and urokinase-type plasminogen activator levels as predictors of pleurodesis outcome and prognosticators in patients with malignant pleural effusion: a prospective cohort studyVaccine-mediated immunotherapy directed against a transcription factor driving the metastatic process.Osteopontin splice variants differentially exert clinicopathological features and biological functions in gastric cancerElevated circulating levels of osteopontin are associated with metastasis in advanced non-small cell lung cancer.Effect of a 12-month exercise intervention on serum biomarkers of angiogenesis in postmenopausal women: a randomized controlled trial.Human osteopontin: Potential clinical applications in cancer (Review)Osteopontin prevents curcumin-induced apoptosis and promotes survival through Akt activation via alpha v beta 3 integrins in human gastric cancer cells.RNA stability regulates differential expression of the metastasis protein, osteopontin, in hepatocellular cancer.BRCA1 suppresses osteopontin-mediated breast cancer.Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells.Role of inflammation in túbulo-interstitial damage associated to obstructive nephropathy.Osteopontin and vasculogenic mimicry formation are associated with response to neoadjuvant chemotherapy in advanced breast cancer.u-PA inhibitor amiloride suppresses peritoneal metastasis in gastric cancer.Osteopontin induces growth of metastatic tumors in a preclinical model of non-small lung cancer.Osteopontin is overexpressed in colorectal carcinoma and is correlated with P53 by immunohistochemistryThe role of angiogenic and wound repair factors during CMV-accelerated transplant vascular sclerosis in rat cardiac transplants.Osteopontin stimulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells.Increased expression of osteopontin in patients with triple-negative breast cancer.Prognostic implications of the co-detection of the urokinase plasminogen activator system and osteopontin in patients with non-small-cell lung cancer undergoing radiotherapy and correlation with gross tumor volume.Osteopontin--an important downstream effector of S100A4-mediated invasion and metastasis.
P2860
Q28249112-4E28B54E-372C-499E-B698-8021A1DB3260Q33405445-A77DEB4E-4422-49EE-8768-322D53E1297CQ33675150-36A557D5-8FAA-41B5-BEF6-E794D5584964Q33713013-2AAF9443-B8A1-4BC9-BC57-8C93246D5F92Q33797395-F9D2AE35-3828-4B6D-BDDC-616A98195A66Q34173692-0DD879CB-A0AA-4F46-B0AF-DE5300E82217Q35221922-B5519607-C40E-4E31-9390-886256887B2FQ35682597-1AA4A590-A7B9-4F90-A539-66913B41E878Q35735299-9AFF43BC-AF29-4DBD-A533-308D90C7D436Q36076565-51564DB3-4E4A-4184-AFEC-5D0AA6341448Q36420021-8093C074-A7DD-4E46-8344-9BED5D9366DAQ36503987-207260E2-B7D9-42CC-9B1B-56DB23C4502FQ36654589-0AD336BB-C31C-4893-8893-6C632A7FB010Q37686655-1E04BFF7-BE7F-4F75-A5EF-3CCC1A131BF3Q39261041-B366BA53-E5DF-4ED2-9176-CF040678C008Q39930173-CEF6D27B-9716-47B3-9B0B-7CD40E3FAB13Q39972907-84034A10-99F6-4684-BC14-89B7FC95AD12Q40261707-2CA7639D-1EA0-4E21-9265-356D403B8BE5Q40317325-9263FDDB-6BFA-465E-B712-619646E32593Q40653460-15E97328-EBCA-42B2-9431-D18FDA54A1D5Q41522574-F3F9F49C-89DB-42C0-8531-DC38A978F83FQ41820104-9696531B-00C0-4048-88F5-FF081C753951Q42063955-D685CD7C-61E5-4763-ADAE-ECCB8174C571Q42218091-7726A61C-B562-4CDB-8022-28DD238418F7Q44389500-843CF06A-8431-403D-860B-6DFFB841CA9CQ44456465-33799DCC-5AC5-4020-AD72-339F670FB224Q46614864-22489E5C-5682-4258-9A6D-C84D117F7B1CQ50014444-857502DE-965A-43F7-A78F-3A22FB7A7FCCQ54405936-657864D9-992B-4783-820C-D423096B40C6
P2860
Osteopontin(OPN)-induced increase in human mammary epithelial cell invasiveness is urokinase (uPA)-dependent.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Osteopontin(OPN)-induced incre ...... is urokinase (uPA)-dependent.
@en
type
label
Osteopontin(OPN)-induced incre ...... is urokinase (uPA)-dependent.
@en
prefLabel
Osteopontin(OPN)-induced incre ...... is urokinase (uPA)-dependent.
@en
P2860
P356
P1476
Osteopontin(OPN)-induced incre ...... is urokinase (uPA)-dependent.
@en
P2860
P2888
P304
P356
10.1023/A:1013095329825
P407
P577
2001-12-01T00:00:00Z
P5875
P6179
1052184559